News & Perspective

Jan 19, 2018

Jan 19, 2018

News Scan for Jan 19, 2018

HHS government shutdown plan
Saudi MERS
Mutated flu virus for vaccine
Yellow fever in Brazil
Polio in Afghanistan

Jun 24, 2016

Jun 24, 2016

News Scan for Jun 24, 2016

White House Zika funding threat
Saudi MERS update
Flu vaccine developments
CDC lab incident disclosures
Measles susceptibility estimate

Jul 02, 2015

Jul 02, 2015
Vaccine vials

GSK upgrade delays supply of adjuvanted H5N1 vaccine

A recommendation for occupational use was tabled until the vaccine becomes available.

Mar 10, 2015

Mar 10, 2015

Flu Scan for Mar 10, 2015

More queries on flu vaccine mismatch
Global flu activity

Oct 27, 2014

Oct 27, 2014

CSL-Novartis deal includes US cell-based flu vaccine plant

The $275 million deal will make the company the second leading player in the $4 billion global flu vaccine market.

May 10, 2013

May 10, 2013

Experts offer dim view of potential vaccine response to H7N9

If the H7N9 influenza virus now circulating in China evolves into a pandemic strain, the world is likely to have great difficulty providing adequate supplies of an effective vaccine in time to blunt its impact, according to a viewpoint article by three experts in the Journal of the American Medical Association (JAMA).

Jan 17, 2013

Jan 17, 2013

FDA approves first flu vaccine grown in insect cells

(CIDRAP News) – The US Food and Drug Administration (FDA) has approved the first influenza vaccine produced with the help of an insect virus and recombinant DNA technology, an approach the agency says may make it possible to start production faster in the event of a flu pandemic.

Nov 21, 2012

Nov 21, 2012

FDA clears first cell-based flu vaccine

(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved the nation's first cell-based flu vaccine, a product from Novartis that uses technology that could help vaccinate more Americans in a pandemic but still has many of the same limitations of older egg-based flu vaccines.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»